Ascentage Pharma Group International (HK:6855) has released an update.
Ascentage Pharma Group International has confidentially filed a draft registration statement for an initial public offering of American depositary shares in the U.S. The timing and pricing details of the offering are not yet determined, and the IPO is contingent on SEC review and market conditions. Shareholders and potential investors are advised to exercise caution when dealing in the company’s securities.
For further insights into HK:6855 stock, check out TipRanks’ Stock Analysis page.
